Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Pharma Holdings AS
Tromsø, Norway
A
1-10 Employees
-
Key takeaway
Pharma Holdings AS specializes in developing novel antimicrobial peptides aimed at treating microbial infections. Their innovative approach, rooted in research from the University of Tromsø, focuses on creating effective drugs that can combat bacterial biofilms and enhance the fight against global infections.
Reference
Core business
Pharma Holdings – The new generation antimicrobial peptides
Thelper
Oslo, Norway
A
1-10 Employees
2019
Key takeaway
Thelper AS is focused on developing innovative immunotherapies that target viral antigens highly expressed in tumors but absent in healthy tissue. Their approach aims to create first-in-class treatments that could transform the therapy landscape for solid tumors, potentially reducing toxicity for patients.
Reference
Core business
Thelper AS
EXACT THERAPEUTICS AS
Oslo, Norway
A
1-10 Employees
2012
Key takeaway
EXACT Therapeutics AS is a clinical-stage biopharmaceutical company that is developing Acoustic Cluster Therapy (ACT®), a novel ultrasound-mediated technology platform designed to enhance the delivery of various therapeutic agents, including those used in oncology and gene therapy. Their approach focuses on improving the precision and effectiveness of standard treatments, which could be relevant for advancements in peptide therapeutics.
Reference
Core business
Company — EXACT THERAPEUTICS
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Biovotec
Oslo, Norway
A
1-10 Employees
2015
Key takeaway
Biovotec is focused on developing innovative wound care products, highlighting their pioneering medical device, Dermarep®, which utilizes Purified Eggshell Membrane Protein (PEP®) technology.
Reference
Product
BIOVOTEC - Dermarep®: 1st biological matrix based on PEP® technology
Biovotec has developed Dermarep®, the 1st biological matrix based on PEP® technology: Purified Eggshell Membrane Protein for wound care...
Diatec Monoclonals AS
Oslo, Norway
A
51-100 Employees
1988
Key takeaway
Curida Diatec is a biotechnology company with extensive experience in antibody production and conjugation, which may be relevant for developments in peptide therapeutics. Their commitment to quality is underscored by their ISO 9001 and GMP-certified production facilities.
Reference
Core business
GMP Site - Curida Diatec
MIM PHARMA
Oslo, Norway
A
11-50 Employees
2013
Key takeaway
MIM Pharma is a science-driven organization focused on improving human health through innovative medical solutions. They have developed a natural plant-based antiviral and immune-enhancing solution, which has shown effectiveness against COVID-19 and influenza, highlighting their commitment to addressing pressing health challenges.
Reference
Core business
MIM PHARMA
Neomed Management
Oslo, Norway
A
1-10 Employees
1997
Key takeaway
NeoMed Management is an investment firm that focuses on the healthcare industry, including emerging companies developing innovative medical products in pharmaceuticals.
Reference
Core business
Neomed - Homepage
Bioinvent International AB
Rana, Norway
A
1-10 Employees
2018
Key takeaway
BioInvent is a clinical-stage company focused on developing innovative antibody-based immunotherapies for cancer. Their unique pipeline targets both hematological cancers and solid tumors, positioning them well in the expanding immunotherapy market.
Reference
Product
n-CoDeR | BioInvent
ClexBio
Oslo, Norway
A
1-10 Employees
2020
Key takeaway
ClexBio is a pre-clinical stage regenerative medicine company focused on innovative tissue engineering solutions. Their proprietary technology platform and expertise in cell biology position them at the forefront of developing advanced therapeutic approaches.
Reference
Core business
ClexBio | Engineering Human Tissue Transplants
ClexBio is a biotech company creating innovative solutions for tissue engineering and single-cell techniques using advanced microfluidics and the proprietary CLEX hydrogel technology.
Palion Medical
Trondheim, Norway
A
11-50 Employees
2018
Key takeaway
The company is developing a novel neurostimulation system that targets occipital nerves to reduce the pain and frequency of severe headaches, including chronic migraines and cluster headaches. Their innovative approach utilizes precision-targeted injections, enhancing the effectiveness of neuromodulation therapies for headache relief.
Reference
Core business
Man & Science
Technologies which have been searched by others and may be interesting for you:
When exploring the peptide therapeutics industry in Norway, several key considerations come into play. The regulatory landscape is crucial, as the Norwegian Medicines Agency oversees the approval processes, ensuring compliance with both national and European Union regulations. This can affect the speed of bringing new therapies to market. The industry faces challenges including high research and development costs and the complexity of peptide synthesis, which can impact profitability and scalability. However, opportunities abound due to Norway’s strong focus on biotechnology and health innovation, supported by government investments in research and development. Environmental concerns also play a role, as the industry must adhere to sustainable practices in manufacturing and waste management. The competitive landscape features both established pharmaceutical companies and emerging biotech firms, fostering a dynamic market. Additionally, the global relevance of peptide therapeutics is expanding, driven by increasing demand for targeted therapies in areas such as oncology and metabolic diseases. Understanding these factors is essential for anyone looking to navigate the peptide therapeutics sector in Norway effectively.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | Norway |
| Amount of fitting manufacturers | 36 |
| Amount of suitable service providers | 11 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1988 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Other, Biotechnology, Medical, IT, Software and Services, Finance and Insurance
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.